Stoke Therapeutics (STOK) Return on Sales (2022 - 2026)
Stoke Therapeutics (STOK) posted quarterly Return on Sales of 0.08% for Q1 2026, down 9.0% year-over-year from 0.09% in Q1 2025, and up 81.97% quarter-over-quarter from 0.45% in Q4 2025.
Stoke Therapeutics (STOK) Return on Sales (2022 - 2026) Analysis & Trends
Stoke Therapeutics' Return on Sales history runs 5 years deep, the most recent figure standing at 0.08% for Q1 2026.
- In Q1 2026, Return on Sales fell 9.0% year-over-year to 0.08%; the TTM figure through Mar 2026 stood at 0.05% (down 6.0% YoY), while the FY2025 annual figure was 0.01%, up 2.0% from the prior year.
- Return on Sales for Q1 2026 stood at 0.08%, up from 0.45% in the prior quarter.
- The five-year high for Return on Sales was 0.01% in Q1 2025, with the low at 0.58% in Q4 2023.
- The 5-year median for Return on Sales is 0.08% (2026), against an average of 0.13%.
- The sharpest annual moves came in 2024 and 2025: Return on Sales jumped 57 bps in 2024, then plunged 44 bps in 2025.
- Stoke Therapeutics' Return on Sales stood at 0.38% in 2022, then sank by 52 bps to 0.58% in 2023, then soared by 99 bps to 0.01% in 2024, then plunged by 6731 bps to 0.45% in 2025, then soared by 82 bps to 0.08% in 2026.
- Business Quant data shows STOK's Return on Sales at 0.08% in Q1 2026, 0.45% in Q4 2025, and 0.04% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 0.00% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.00% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.00% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.00% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.00% |
| 10 | Stoke Therapeutics | 1.95 Bn | 1.66 Bn | - | -0.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.07% |
| Mar 31, 2026 | -0.08% |
| Dec 31, 2025 | -0.45% |
| Sep 30, 2025 | -0.04% |
| Jun 30, 2025 | -0.02% |
| Mar 31, 2025 | 0.01% |
| Dec 31, 2024 | -0.01% |
| Sep 30, 2024 | -0.05% |
| Jun 30, 2024 | -0.05% |
| Mar 31, 2024 | -0.06% |
| Dec 31, 2023 | -0.58% |
| Sep 30, 2023 | -0.08% |
| Jun 30, 2023 | -0.15% |
| Mar 31, 2023 | -0.05% |
| Dec 31, 2022 | -0.38% |
| Sep 30, 2022 | -0.10% |
| Jun 30, 2022 | -0.10% |
| Mar 31, 2022 | -0.09% |